Cerebral lupus vasculopathy

Mechanisms and clinical relevance

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The most common neuropathological findings in SLE are a small vessel cerebral vasculopathy and microinfarcts. These findings may reflect the end result of repeated episodes of acute inflammation in the small vessels in the brain. There is experimental support for the local Shwartzman reaction as a paradigm to explain some of the CNS manifestations in SLE. Activation or 'priming' of cerebral microvascular endothelial cells by anticardiolipin antibodies or other immunoglobulins in concert with intravascular activation of the complement system may combine to elicit leukothrombosis in the brain. Therapies aimed at inhibiting leukocyte-endothelial cell interactions in the brain may be of use in CNS lupus.

Original languageEnglish (US)
Pages (from-to)154-168
Number of pages15
JournalAnnals of the New York Academy of Sciences
Volume823
DOIs
StatePublished - Jan 1 1997

Fingerprint

Brain
Endothelial cells
Endothelial Cells
Shwartzman Phenomenon
Chemical activation
Anticardiolipin Antibodies
Complement Activation
Cell Communication
Immunoglobulins
Leukocytes
Inflammation
Cells
Activation
Central Nervous System
Vessel
Therapeutics
Interaction
Paradigm
Therapy
Manifestation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Cerebral lupus vasculopathy : Mechanisms and clinical relevance. / Hess, David C.

In: Annals of the New York Academy of Sciences, Vol. 823, 01.01.1997, p. 154-168.

Research output: Contribution to journalArticle

@article{7d65da583c904d7b9b0c13f2278f5645,
title = "Cerebral lupus vasculopathy: Mechanisms and clinical relevance",
abstract = "The most common neuropathological findings in SLE are a small vessel cerebral vasculopathy and microinfarcts. These findings may reflect the end result of repeated episodes of acute inflammation in the small vessels in the brain. There is experimental support for the local Shwartzman reaction as a paradigm to explain some of the CNS manifestations in SLE. Activation or 'priming' of cerebral microvascular endothelial cells by anticardiolipin antibodies or other immunoglobulins in concert with intravascular activation of the complement system may combine to elicit leukothrombosis in the brain. Therapies aimed at inhibiting leukocyte-endothelial cell interactions in the brain may be of use in CNS lupus.",
author = "Hess, {David C}",
year = "1997",
month = "1",
day = "1",
doi = "10.1111/j.1749-6632.1997.tb48388.x",
language = "English (US)",
volume = "823",
pages = "154--168",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Cerebral lupus vasculopathy

T2 - Mechanisms and clinical relevance

AU - Hess, David C

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The most common neuropathological findings in SLE are a small vessel cerebral vasculopathy and microinfarcts. These findings may reflect the end result of repeated episodes of acute inflammation in the small vessels in the brain. There is experimental support for the local Shwartzman reaction as a paradigm to explain some of the CNS manifestations in SLE. Activation or 'priming' of cerebral microvascular endothelial cells by anticardiolipin antibodies or other immunoglobulins in concert with intravascular activation of the complement system may combine to elicit leukothrombosis in the brain. Therapies aimed at inhibiting leukocyte-endothelial cell interactions in the brain may be of use in CNS lupus.

AB - The most common neuropathological findings in SLE are a small vessel cerebral vasculopathy and microinfarcts. These findings may reflect the end result of repeated episodes of acute inflammation in the small vessels in the brain. There is experimental support for the local Shwartzman reaction as a paradigm to explain some of the CNS manifestations in SLE. Activation or 'priming' of cerebral microvascular endothelial cells by anticardiolipin antibodies or other immunoglobulins in concert with intravascular activation of the complement system may combine to elicit leukothrombosis in the brain. Therapies aimed at inhibiting leukocyte-endothelial cell interactions in the brain may be of use in CNS lupus.

UR - http://www.scopus.com/inward/record.url?scp=0030865985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030865985&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1997.tb48388.x

DO - 10.1111/j.1749-6632.1997.tb48388.x

M3 - Article

VL - 823

SP - 154

EP - 168

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -